Business Context and Reporting Period
Company: PowerVerde, Inc. (Note: Request metadata listed "374Water Inc.", but the filing is for PowerVerde, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2011
Business Stage: Development Stage Company
Operations: The Company focuses on the development, testing, and commercialization of clean energy electric power generation systems. It previously operated a biotech business which was largely divested, though it retains some licensing revenue from that IP. The Company is a smaller reporting company.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2011 | Six Months Ended June 30, 2010 |
|---|---|---|
| Revenue (Net) | $30,991 | $18,687 |
| Cost of Goods Sold | $6,925 | $0 |
| Gross Profit | $24,066 | $18,687 |
| Operating Expenses | $1,689,837 | $190,206 |
| Net Loss | $(1,645,271) | $(171,519) |
| Cash and Cash Equivalents (End of Period) | $496,280 | $45,228 |
| Working Capital | $464,146 | $(132,895) |
| Total Liabilities | $467,652 | $153,891 |
| Stockholders' Equity | $309,714 | $(120,861) |
Cash Flow Summary (Six Months Ended June 30, 2011):
- Cash Used in Operating Activities: $(858,174)
- Cash Used in Investing Activities: $(11,192)
- Cash Provided by Financing Activities: $1,350,000
- Net Increase in Cash: $480,634
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased by approximately 66% year-over-year, driven by $7,221 in current business sales and $23,770 in biotech IP licensing fees. However, revenue remains immaterial relative to expenses.
- Expense Surge: Operating expenses increased by 788% to $1.69 million. This was primarily driven by non-cash stock-based compensation:
- Warrants issued for services: $612,150 (100% increase).
- Stock-based compensation: $284,454 (100% increase).
- Liquidity Improvement: Cash balances increased from $15,646 at year-end 2010 to $496,280 at June 30, 2011. This was achieved through a private placement of common stock raising $1.5 million in gross proceeds.
- Equity Position: The Company moved from a stockholders' deficit of $(120,861) to positive equity of $309,714 due to the capital raise and stock-based compensation adjustments.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Liquidity: Management believes current working capital is sufficient to sustain operations for approximately six months. The Company is actively seeking additional funding from private equity and governmental sources. Failure to raise capital could force a cessation of operations.
Going Concern: The financial statements include a "Going Concern" note. Recurring operating losses and negative cash flows from operations create substantial doubt about the Company's ability to continue as a going concern without additional financing.
Key Agreements and Unusual Items:
- Newton Distribution Agreement: Entered a Binding Letter of Intent (BLOI) with Newton Investments BV for exclusive distribution in the EU. Newton invested $250,000 and paid a $30,000 deposit on an initial system (delivered July 2011, revenue recognized in Q3).
- Treasury Stock Transaction: Co-founder George Konrad surrendered 4.5 million shares to the treasury in exchange for a $200,000 note payable to his related party, due April 2013 (amended August 2011).
- Executive Changes: In August 2011 (subsequent event), George Konrad resigned as CEO/CFO. Richard H. Davis was elected CEO and John L. Hofmann was elected CFO.
Investor Verification Checklist
- Capital Runway: Verify if the Company has secured the additional funding required beyond the estimated six-month runway to avoid operational cessation.
- Revenue Recognition: Confirm the timing of revenue recognition for the Newton system sale ($130,000) and future royalty streams, noting the Company defers revenue until agreements are 100% complete.
- Related Party Transactions: Review the terms of the $200,000 note payable to the related party (Arizona Research and Development) and the conditions for its acceleration upon financing or sale events.
- Dilution Risk: Assess the impact of outstanding warrants (4.5 million shares) and options (1.95 million shares) on future equity dilution.
- Going Concern Status: Monitor subsequent filings for any updates on the "Going Concern" uncertainty and the success of capital raising efforts.